EXPRESSION OF CYTOCHROME-P450-3A5 IN ESCHERICHIA-COLI - EFFECTS OF 5' MODIFICATION, PURIFICATION, SPECTRAL CHARACTERIZATION, RECONSTITUTION CONDITIONS, AND CATALYTIC ACTIVITIES

被引:141
作者
GILLAM, EMJ
GUO, ZY
UENG, YF
YAMAZAKI, H
COCK, I
REILLY, PEB
HOOPER, WD
GUENGERICH, FP
机构
[1] UNIV QUEENSLAND,DEPT PHYSIOL & PHARMACOL,ST LUCIA,QLD 4072,AUSTRALIA
[2] UNIV QUEENSLAND,DEPT BIOCHEM,ST LUCIA,QLD 4072,AUSTRALIA
[3] UNIV QUEENSLAND,DEPT MED,ST LUCIA,QLD 4072,AUSTRALIA
[4] VANDERBILT UNIV,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232
[5] VANDERBILT UNIV,SCH MED,CTR MOLEC TOXICOL,NASHVILLE,TN 37232
关键词
P450; 3A5; ESCHERICHIA COLI; HETEROLOGOUS EXPRESSION; ENZYME PURIFICATION; NIFEDIPINE;
D O I
10.1006/abbi.1995.1177
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 (P450) 3A5 is a human enzyme with 85% amino acid sequence identity to the more predominantly expressed P450 3A4 and has been reported to have overlapping catalytic specificity. The 5'-terminus of a P450 3A5 cDNA was modified for optimal expression in Escherichia coli using the vector pCW, by aligning the MALLLAVFL N-terminal sequence of recombinant bovine P450 17A (H. J. Barnes, M. P. Arlotto, and M. R. Waterman, (1991) Proc. Natl. Acad. Sci. USA 88, 5597-5601) to the 3A5 cDNA. Two constructs were made, differing by their identity with the modified 3A4 N-terminal sequence (E. M. J. Gillam, T. Baba, B-R. Rim, S. Ohmori, and F. P. Guengerich, (1993) Arch. Biochem. Biophys. 305, 123-131). The first modified sequence (3A5#1) was identical to recombinant P450 3A4 up to codon 15, the 3A5 sequence being introduced thereafter. In the other (3A5#2), the successful 3A4 N-terminal nucleotide sequence was attached to codon 30. The yield was greater than fourfold higher in the first construct [up to 260 nmol (liter culture)(-1)]. The recombinant P450 3A5 (construct 1) was purified to electrophoretic homogeneity using a variation of a three-step procedure developed previously for P450 3A4, with an overall yield of similar to 40%. Purified P450 3A5 was active in nifedipine oxidation, testosterone 6 beta-hydroxylation, aflatoxin 3 alpha-hydroxylation and 8,9-epoxidation, N-ethylmorphine N-demethylation, erythromycin N-demethylation, and d-benzphetamine N-demethylation. The reconstitution of nifedipine oxidation, testosterone 6 beta-hydroxylation, and the aflatoxin oxidation activities showed dependence upon the presence of cytochrome b(5), divalent cations, phospholipid mixtures, glutathione, and cholate similar to that previously found for purified P450 3A4. However, rates of the N-demethylations of N-ethylmorphine, erythromycin, and d-benzphetamine were as high or higher for P450 3A5 than P450 3A4 and were not particularly dependent upon modifications of reconstitution systems. (C) 1995 Academic Press, Inc.
引用
收藏
页码:374 / 384
页数:11
相关论文
共 64 条
[51]  
SCHUETZ JD, 1994, J CLIN INVEST, V4, P11
[52]   HUMAN CYTOCHROME-P450-3A4 - ENZYMATIC-PROPERTIES OF A PURIFIED RECOMBINANT FUSION PROTEIN CONTAINING NADPH-P450 REDUCTASE [J].
SHET, MS ;
FISHER, CW ;
HOLMANS, PL ;
ESTABROOK, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11748-11752
[53]  
SHIMADA T, 1986, J BIOL CHEM, V261, P909
[54]  
SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414
[55]   EFFECT OF DIVALENT-CATIONS ON NADH-DEPENDENT AND NADPH-DEPENDENT CYTOCHROME-B5 REDUCTION BY HEPATIC MICROSOMES [J].
TAMURA, M ;
YOSHIDA, S ;
TAMURA, T ;
SAITOH, T ;
TAKESHITA, M .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1990, 280 (02) :313-319
[56]   4-(4-NITROBENZYL)PYRIDINE TESTS FOR ALKYLATING-AGENTS FOLLOWING CHEMICAL OXIDATIVE ACTIVATION [J].
THOMAS, JJ ;
KIM, JH ;
MAURO, DM .
ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 1992, 22 (02) :219-227
[57]   IDENTIFICATION OF AN INDUCIBLE FORM OF CYTOCHROME-P-450 IN HUMAN-LIVER [J].
WATKINS, PB ;
WRIGHTON, SA ;
MAUREL, P ;
SCHUETZ, EG ;
MENDEZPICON, G ;
PARKER, GA ;
GUZELIAN, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (18) :6310-6314
[58]   SILVER STAINING OF PROTEINS IN POLYACRYLAMIDE GELS [J].
WRAY, W ;
BOULIKAS, T ;
WRAY, VP ;
HANCOCK, R .
ANALYTICAL BIOCHEMISTRY, 1981, 118 (01) :197-203
[59]   THE HUMAN HEPATIC CYTOCHROMES-P450 INVOLVED IN DRUG-METABOLISM [J].
WRIGHTON, SA ;
STEVENS, JC .
CRITICAL REVIEWS IN TOXICOLOGY, 1992, 22 (01) :1-21
[60]  
WRIGHTON SA, 1990, MOL PHARMACOL, V38, P207